Pulmonary embolism (PE) is a medical condition in which a blood clot blocks one or more arteries in the lungs. It is a serious complication of deep vein thrombosis (DVT), a condition in which a blood clot forms in a deep vein, usually in the leg. PE is a major cause of death in cardiology, and is estimated to affect up to 600,000 people in the United States each year. Symptoms of PE include chest pain, shortness of breath, and coughing up blood. Diagnosis is typically made through imaging tests such as computed tomography (CT) scans or echocardiograms. Treatment typically involves anticoagulant medications to prevent further clotting, and in some cases, clot-dissolving medications or surgery.
Companies in the Pulmonary Embolism market include Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, and Bristol-Myers Squibb. Show Less Read more
